Antimicrobial Therapy: Rifampin, Glycopeptides, Nitrofurans, Ionophores, Polypeptides, Mupirocin Flashcards

1
Q

Rifampin

A
  • Derived form rifamycin C produced by Amycolatopsis rifamycinica
  • Bactericidal
  • T>MIC
  • Resistance is due to target mutations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rifampin:

Spectrum

A

Gram positve aerobes, Staphylococcus, Rhodococcus, Chlamydophila and Anaerobes

Drug of choice for Rhodococcus in foals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Rifampin:

MOA

A

bind to RNA polymerase inhibiting RNA synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rifampin:

Absorption

A

well absorbed in most species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rifampin:

Distribution

A

moderate protein binding, but highly lipophilic penetrating cellular membranes, CNS, Prostate, and Bronchiole fluid.

It has poor penetration into aqueous humor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rifampin:

Metabolism

A

not specifically assessed in veterinary species.

In humans, it is extensively metabolized and some metabolites are active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rifampin

Elimination

A

Only a small amount is eliminated inthe urine as active drug / metabolite

Is suficient in concentration to be effective for UTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rifampin:

Adverse Effects

A

Vomiting, Anorexia, Diarrhea

Hepatic (up to and including tru toxicity) - Need to monitor chemistry profile

CYP induction: enhances metabolism of other drugs metabolized by CYT3A)

cyclosporin, digoxin, cisapride, diazepam, chloramphenicol

Discoloration of body fluids (tears, saliva) and urine to an orange/red color

Bad tasting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nitrofurantoin:

Absorption

A

well absorbed after oral administration

Microcrystalline formulations rapidly absorbed, more likely to cuase nausea and vomiting

Macrocrystalline formulations slowly absorbed, less GI upset

Feeding does not affect absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nitrofurantoin:

Distribution

A

poor tissue distribution and short drug expsosure

Moderate protein binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nitrofurantoin:

Metabolism

A

a small amount of metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nitrofurantoin:

Elimination

A

high concentrations of drug in urine, small amounts in bile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Nitrofurantoin:

MOA

A

bacteria metabolize to reactive metabolites inhibiting bacterial energy metabolism and protien, DNA, RNA, and cell wall synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nitrofurantoin:

Spectrum

A

Gram postive, and gram negative urinary pathogens including:

Enterococcus

Proteus and Pseudomonas are intrinsically resistant

Time dependent (T>MIC)

Bacteriostatic to bactericidal depending on concentration and MIC

Activity is limited ot UTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nitrofurantoin:

Adverse Effects

A

Nausea, vomiting, brown colored urine

Neuropathy has been reported in humans treated ling term and may occur in dogs with long term admin,

Do NOT use in azotemic patients (increase adverse effects, decreases efficacy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Nitrofurantoin:

Clinical Use

A

UTIs in nonazotemic animals when more common antimicrobials cannot be administered

17
Q

Nitrofurans in Food Animals

A

No Allowable extralable use in food animals

Including topical medication

18
Q

Ionophores:

Menosin

A

Originally isolated form streptomyces cinnamonensis and lasalocid most common

19
Q

Ionophores:

MOA

A
  • Act on cell wall causing ion fluxes resulting in changes of intracellular pH and subsequent bacterial death
    • Gram positive bacteria, coccidia
  • Alters rumen flora shifting volatile fatty acid production form lactic acid to propionic acid resulting in better glucose metabolism and feed conversion
  • Alters metabolism of lactic acid decreasing formations of 3-methylindole which is pneumotoxin resulting in severe respiratory distress “fog fever”
  • Fog fever typically happens when cattle move to a more lush pasture in the fall
    • A 1-6 day lead time feeding ionophores is needed to prevent
20
Q

Ionophore:

Adverse Effects

A
  • In general, well tolerated
  • Toxicity is due to cell membrane disruption in cardiac and skeletal muscle
    • Horse and cattle: cardiac > skeletal
    • Sheep: skeletal > cardiac
    • Horses are very sensitive to monensin toxicity
    • Toxicity in ruminants is typically due to improper feed formulation of mixing
    • Remember to account for ionophores in cases of polypharmacy
21
Q

Bambermycins

A

originally isolated for Streptomyces

Uses: feed additive to imporve feed efficiency in cattle, swine, chickens, turkeys. Also decreases shedding of E. coli, Salmonella

22
Q

Bambermycins:

MOA

A

Inhibits cell wall synthesis through inhibition of peptidoglycan glycosynthransferase

23
Q

Bambermycins:

Spectrum

A

Gram positive

24
Q

Polypeptides:

Bacitracin

A
  • Originally isolated for Bacillus subtilis
  • commonly used in topical formulations
  • Approved for use in feed additive beef cattle, swine, chickens, turkeys, quail, pheasant
  • No ELDU for feed additive
25
Q

Polypeptides:

Bacitracin:

MOA

A

inhibits peptidoglycan formation in bacterial cell walls

26
Q

Polypeptides:

Bacitracin:

Spectrum

A

Gram positive

27
Q

Polypeptides:

Bacitracin:

Adverse Effects

A

Highly nephrotoxic, therefore only topical

Oral not absorbed form GIT = topical administration

28
Q

Mupirocin

A

Originally isolated from Pseudomonas fluorescens

Topical use primarily for dermatologic infections caused by gram positive including methicillin resistant Staphylococcus

There is minor acitivy agianst gram negative and anaerobes

29
Q

Mupirocin:

MOA

A

binding to an RNA synthetase

30
Q

Mupirocin:

Adverse Effects

A

since this is a topical it is well tolerated, potential for some skin irritation,

Do NOT infuse into deep wounds as systemic absorption can occur

31
Q

Silver Sulfadiazine

SSD

A

Topical use - often used in human burn patients

Poor solubility leads to little systemic silver absorption even in open wounds

32
Q

SSD

Spectrum

A

including gram positve, gram negative, some anaerobes and yeast and fungal

33
Q

SSD

mechanism

A

not well defined

34
Q

SSD:

Adverse Effects

A

sulfadiazine effects as well as silver effects may contribute to overall efficacy

Silver may:

Bind to DNA base pairs blocking transcription

BInd to cell surface interfering with respiration

Prevent phosphate uptake